Your browser doesn't support javascript.
loading
Re-directing nanomedicines to the spleen: A potential technology for peripheral immunomodulation.
Kaur, Satinderdeep; Allan, Stuart M; Al-Ahmady, Zahraa S.
Affiliation
  • Kaur S; Pharmacology Department, School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, United Kingdom.
  • Allan SM; Division of Neuroscience and Experimental psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, AV Hill Building, Manchester M13 9PT, United Kingdom; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Group, University of Manchester, Manchester, United Kingdom.
  • Al-Ahmady ZS; Pharmacology Department, School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, United Kingdom; School of Pharmacy and Optometry, Faculty of Biology, Medicine, and Health, AV Hill Building, The University of Manchester, Manchester M13 9PT, United Kingdom. Electronic address: zahraa.alahmady@ntu.ac.uk.
J Control Release ; 350: 60-79, 2022 10.
Article in En | MEDLINE | ID: mdl-35405164

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spleen / Stroke Limits: Animals Language: En Journal: J Control Release Journal subject: FARMACOLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spleen / Stroke Limits: Animals Language: En Journal: J Control Release Journal subject: FARMACOLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication: